Influence of seminal plasma on female reproductive function

1. Robertson S.A., Sharkey D.J. Seminal fluid and fertility in women. Fertil. Steril. 2016; 106(3): 511-9.

2. Wolters-Everhardt E., Dony J.M., Peters W.H., De Pont J.J. Buffering substances of human semen. Fertil. Steril. 1987; 48(1): 159-61.

3. Maxwell W.M., de Graaf S.P., Ghaoui Rel-H., Evans G. Seminal plasma effects on sperm handling and female fertility. Soc. Reprod. Fertil. 2007; 64(Suppl.): 13-38.

4. Clark D.A., Fernandes J., Banwatt D. Prevention of spontaneous abortion in the CBA x DBA/2 mouse model by intravaginal TGF-beta and local recruitment of CD4+8+ FOXP3+ cells. Am. J. Reprod. Immunol. 2008; 59(6): 525-34.

5. Kho E.M., McCowan L.M., North R.A., Roberts C.T., Chan E., Black M.A. et al. Duration of sexual relationship and its effect on preeclampsia and small for gestational age and perinatal outcome. J. Reprod. Immunol. 2009; 82: 66-73.

6. Crawford G., Ray A., Gudi A., Shah A., Homburg R. The role of seminal plasma for improved outcomes during in vitro fertilization treatment: review of the literature and meta-analysis. Hum. Reprod. Update. 2015; 21(2): 275-84.

7. Robertson S.A. Seminal plasma and male factor signaling in the female reproduction tract. Cell Tissue Res. 2005; 322(1): 43-52.

8. Schjenken J.E., Glynn D.J., Sharkey D.J., Robertson S.A. TLR4 signaling is a major mediator of the female tract response to seminal fluid in mice. Diol. Reprod. 2015; 93: 68.

9. Robertson S.A., Mau V.J., Tremellen K.P., Seamark R.F. Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice. J. Reprod. Fertil. 1996; 107(2): 265-77.

10. De M., Choudhuri R., Wood G.W. Determination of the number and distribution of macrophages, lymphocytes, and granulocytes in the mouse uterus from mating through implantation. J. Leukoc. Biol. 1991; 50(3): 252-62.

11. Moldenhauer L.M., Diener K.R., Thring D.M., Brown M.P., Hayball J.D., Robertson S.A. Cross-presentation of male seminal fluid antigens elicits Tcell activation to initiate the female immune response to pregnancy. J. Immunol. 2009; 182(12): 8080-93.

12. Robertson S.A., Guerin L.R., Bromfield J.J., Branson K.M., Ahlstrom A.C., Care A.S. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 2009; 80(5): 1036-45.

13. Guerin L.R., Prins J.R., Robertson S.A. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update. 2009; 15(5): 517-35.

14. Robertson S.A., Ingman W.V., O’Leary S., Sharkey D.J., Tremellen K.P. Transforming growth factor beta-a mediator of immune deviation in seminal plasma. J. Reprod. Immunol. 2002; 57(1-2): 109-28.

15. Bromfield J.J., Schjenken J.E., Chin P.Y., Care A.S., Jasper M.J., Robertson S.A. Maternal tract factors contribute to paternal seminal fkuid impact on metabolic phenotype in offspring. Proc. Natl. Acad. Sci. USA. 2014; 111(6): 2200-5.

16. Poon H.K., Lee K.H., Wong C.L., O W.S., Chow P.H. Absence of paternal accessory sex gland secretions disturbs epigenetic reprogramming and expression of Igf2 and Dlk1 in golden hamster embryos. Theriogenology. 2009; 71(9):1367-80.

17. Kupka M.S., Ferraretti A.P., de Mouzon J., Erb K., D’Hooghe T., Castilla J.A. et al.; European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE. Hum. Reprod. 2014; 29(10): 2099-113.

18. Корсак В.С., Смирнова А.А., Шурыгина О.В. ВРТ в России. Отчет за 2013 год. Регистр ВРТ. СПб.: Российская Ассоциация Репродукции Человека; 2015: 26-9. [Korsak V.S., Smirnova A.A., Shurygina O.V. ART in Russia. The report for 2013. Register of ART. St. Petersburg: Russian Association of Human Reproduction; 2015: 26-9. (in Russian)]

19. Bellinge B.S., Copeland C.M., Thomas T.D., Mazzuccelli R.E., O’Neil G., Cohen M.J. The influence of patient insemination on the implantation rate in an vitro fertilization and embryo transfer program. Fertil. Steril. 1986; 46(2): 252-6.

20. Tremellen K.P., Vlbuena D., Landeras J., Ballesteros A., Martinez J., Mendoza S. et al. The effect of intercourse on pregnancy rates during assisted human reproduction. Hum. Reprod. 2000; 15(12): 2653-8.

21. Chicea R., Ispasoiu F., Focsa M. Seminal plasma insemination during ovum-pickup-a method to increase pregnancy rate in IVF/ICSI procedure. A pilot randomized trial. J. Assist. Reprod. Genet. 2013; 30(4): 569-74.

22. Von Wolff M., Rosner S., Germeyer A., Jauckus J., Griesinger G., Strowitzki T. Intrauterine instillation of diluted seminal plasma at oocyte pick-up does not increase the IVF pregnancy rate: a double-blind, placebo controlled, randomized study. Hum. Reprod. 2013; 28(12): 3247-52.

23. Politch J.A., Tucker L., Bowman F.P., Anderson D.J. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum. Reprod. 2007; 22(11): 2928-35.

24. Soucek K., Slabáková E., Ovesná P., Malenovská A., Kozubík A., Hampl A. Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma. Hum. Reprod. 2010; 25(12): 2962-71.

25. Fish E.N. The X-files in immunity: sex-based differences predispose immune responces. Nat. Rev. Immunol. 2008; 8(9): 737-44.

26. Gutsche S., von Wolff M., Strowitzki T., Thaler C.J. Seminal plasma induced mRNA expression of IL-beta, IL-6 and LIF in endometrial epithelial cells in vitro. Mol. Hum. Reprod. 2003; 9(12): 785-91.

27. Dinarello C.A., Novick D., Kim S., Kaplanski G. Interleukin-18 and IL-18 binding protein. Front. Immunol. 2013; 4: 289.

28. Nikolaeva M.A., Babayan A.A., Stepanova E.O., Smolnikova V.Y., Kalinina E.A., Fernández N. et al. The relationship of seminal transforming growth factor-β1 and interleukin-18 with reproductive success in women exposed to seminal plasma during IVF/ICSI treatment. J. Reprod. Immunol. 2016;117: 45-51.

29. Davies M.J., March W.A., Wilson K.J., Giles L.C., Moore V.M. Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood. Hum. Reprod. 2012; 27(5): 1475-80.

30. Bower C., Hansen M. Assisted reproductive technologies and birth outcomes: overview of recent systematic reviews. Reprod. Fertil. Dev. 2005; 17(3): 329-33.

31. Hart R., Norman R.J. The longer-term health outcomes for children born as a result of IVF treatment. Part I. General health outcomes. Hum. Reprod. Update. 2013; 19(3): 232-43.

32. Shankaran S. Outcomes from infancy to adulthood after assisted reproductive technology. Fertil. Steril. 2014; 101(5): 1217-21.

33. Dekker G. The partner’s role in the etiology of preeclampsia. J. Reprod. Immunol. 2002; 57(1-2): 203-15.

34. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010; 63(6): 534-43.

35. Saftlas A.F., Rubenstein L., Prater K., Harland K.K., Field E., Triche E.W. Cumulative exposure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia. J. Reprod. Immunol. 2014; 101-102:104-10.

36. Wang J.X., Knottnerus A.M., Schuit G., Norman R.J., Chan A., Dekker G.A. Surgically obtained sperm, and risk of gestational hypertension and preeclampsia. Lancet 2002; 359(9307): 673-4.

37. Smith G.N., Walker M., Tessier J.L., Millar K.G. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am. J. Obstet. Gynecol. 1997; 177(2): 455-8.

38. Kyrou D., Kolibianakis E.M., Devroey P., Fatemi H.M. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertil. Steril. 2010; 93(4): 1124-7.

Received 09.12.2016

Accepted 23.12.2016